Good manufacturing practice-grade cytotoxic T lymphocytes specific for latent membrane proteins (LMP)-1 and LMP2 for patients with Epstein-Barr virus-associated lymphoma

被引：24
作者：
Bollard, Catherine M. [1 ,2 ,3 ,4 ]
Gottschalk, Stephen [1 ,2 ,3 ]
Huls, M. Helen [1 ]
Leen, Ann M. [1 ,2 ]
Gee, Adrian P. [1 ,2 ,4 ]
Rooney, Cliona M. [1 ,2 ,3 ,5 ]
机构：
[1] Baylor Coll Med, Methodist Hosp, Ctr Cell & Gene Therapy, Houston, TX 77030 USA
[2] Baylor Coll Med, Methodist Hosp, Dept Pediat, Houston, TX 77030 USA
[3] Baylor Coll Med, Methodist Hosp, Dept Immunol, Houston, TX 77030 USA
[4] Baylor Coll Med, Methodist Hosp, Dept Med, Houston, TX 77030 USA
[5] Baylor Coll Med, Methodist Hosp, Dept Virol, Houston, TX 77030 USA
来源：
CYTOTHERAPY | 2011年 / 13卷 / 05期
关键词：
T-cell immunotherapy; standard operating procedures; ANTIGEN-PRESENTING CELLS; EXPANSION; CTLS;
D O I：
10.3109/14653249.2011.561983
中图分类号：
Q813 [细胞工程];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：518 / 522
页数：5
相关论文
共 13 条
[1]   Complete responses of relapsed lymphoma following genetic modification of tumor-antigen presenting cells and T-lymphocyte transfer [J].
Bollard, Catherine M. ;
Gottschalk, Stephen ;
Leen, Ann M. ;
Weiss, Heidi ;
Straathof, Karin C. ;
Carrum, George ;
Khalil, Mariam ;
Wu, Meng-fen ;
Huls, M. Helen ;
Chang, Chung-Che ;
Gresik, M. Victoria ;
Gee, Adrian P. ;
Brenner, Malcolm K. ;
Rooney, Cliona M. ;
Heslop, Helen E. .
BLOOD, 2007, 110 (08) :2838-2845
[2]   Cytotoxic T lymphocyte therapy for Epstein-Barr virus Hodgkin's disease [J].
Bollard, CM ;
Aguilar, L ;
Straathof, KC ;
Gahn, B ;
Huls, MH ;
Rousseau, A ;
Sixbey, J ;
Gresik, MV ;
Carrum, G ;
Hudson, M ;
Dilloo, D ;
Gee, A ;
Brenner, MK ;
Rooney, CM ;
Heslop, HE .
JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 200 (12) :1623-1633
[3]   The generation and characterization of LMP2-specific CTLs for use as adoptive transfer from patients with relapsed EBV-positive Hodgkin disease [J].
Bollard, CM ;
Straathof, KCM ;
Huls, MH ;
Leen, A ;
Lacuesta, K ;
Davis, A ;
Gottschalk, S ;
Brenner, MK ;
Heslop, HE ;
Rooney, CM .
JOURNAL OF IMMUNOTHERAPY, 2004, 27 (04) :317-327
[4]   Generating CTLs against the subdominant Epstein-Barr virus LMP1 antigen for the adoptive immunotherapy of EBV-associated malignancies [J].
Gottschalk, S ;
Edwards, OL ;
Sili, U ;
Huls, MH ;
Goltsova, T ;
Davis, AR ;
Heslop, HE ;
Rooney, CM .
BLOOD, 2003, 101 (05) :1905-1912
[5]   Contact-activated monocytes: Efficient antigen presenting cells for the stimulation of antigen-specific T cells [J].
Leen, Ann ;
Ratnayake, Maheshika ;
Foster, Aaron ;
Heym, Kenneth ;
Ahmed, Nabil ;
Rooney, Cliona M. ;
Gottschalk, Stephen .
JOURNAL OF IMMUNOTHERAPY, 2007, 30 (01) :96-107
[6]   Allogeneic Virus-Specific T Cells with HLA Alloreactivity Do Not Produce Graft-Versus-Host Disease In Human Subjects. [J].
Melenhorst, J. Joseph ;
Leen, Ann M. ;
Bollard, Catherine M. ;
Quigley, Maire F. ;
Price, David A. ;
Rooney, Cliona M. ;
Brenner, Malcolm K. ;
Barrett, A. John ;
Heslop, Helen E. .
BLOOD, 2010, 116 (21) :537-537
[7]   RELEASE OF INFECTIOUS EPSTEIN-BARR VIRUS BY TRANSFORMED MARMOSET LEUKOCYTES [J].
MILLER, G ;
LIPMAN, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1973, 70 (01) :190-194
[8]   THE USE OF ANTI-CD3 AND ANTI-CD28 MONOCLONAL-ANTIBODIES TO CLONE AND EXPAND HUMAN ANTIGEN-SPECIFIC T-CELLS [J].
RIDDELL, SR ;
GREENBERG, PD .
JOURNAL OF IMMUNOLOGICAL METHODS, 1990, 128 (02) :189-201
[9]   Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes for the treatment of patients with EBV-positiye relapsed Hodgkin's disease [J].
Roskrow, MA ;
Suzuki, N ;
Gan, YJ ;
Sixbey, JW ;
Ng, CYC ;
Kimbrough, S ;
Hudson, M ;
Brenner, MK ;
Heslop, HE ;
Rooney, CM .
BLOOD, 1998, 91 (08) :2925-2934
[10]   Immunotherapeutic options for Epstein-Barr virus-associated lymphoproliferative disease following transplantation [J].
Shaffer, Donald R. ;
Rooney, Cliona M. ;
Gottschalk, Stephen .
IMMUNOTHERAPY, 2010, 2 (05) :663-671
12